In September 2008, the National Vaccine Advisory Committee (NVAC), a federal advisory group, approved a series of recommendations to improve vaccine financing systems in the United States. These 24 recommendations, the final product of 2 years of work, were developed with broad input and consensus from stakeholders, including health-care providers, consumers, insurers, vaccine manufacturers, state and local public health authorities, and state and local government and Medicaid agencies.
The committee recommendations are available at
http://www.hhs.gov/nvpo/nvac/reports.html. A report discussing the issues surrounding vaccine financing and the development of the recommendations is available at
Notice to Readers: National Vaccine Advisory Committee Recommendations on Vaccine Financing. JAMA. 2009;301(22):2322. doi: